ArticlePloS one2025
Relationship between HLA-DRB1 shared epitope alleles and peripheral blood monocyte counts in Japanese patients with rheumatoid arthritis.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo investigate the relationship between Human Leukocyte Antigen-DR beta 1 (HLA-DRB1) shared epitope (SE) alleles and peripheral blood monocyte counts in disease-modifying antirheumatic drug-naïve patients with rheumatoid arthritis (RA), and also the relationship between specific SE alleles and anti-cyclic citrullinated peptide antibody (anti-CCP Ab) titers.
methodsThis retrospective single-center study included 86 Japanese patients with RA. HLA-DRB1 genotyping was performed, and SE alleles associated with a high risk of developing RA were classified into the S2 (*04:01) and S3P (*01:01, *01:02, *04:04, *04:05, *04:08, and *10:01) categories. Patients were stratified based on monocyte count tertiles. The relationships between monocyte counts at diagnosis and clinical, serological, and genetic factors were analyzed. Logistic regression was used to identify independent factors associated with high monocyte counts.
resultsSE-positive patients, particularly those with S3P alleles, had significantly higher monocyte counts than SE-negative patients. A multivariate analysis revealed that male sex and S3P positivity, particularly HLA-DRB1 *01:01 or *04:05, were independently associated with higher monocyte counts. Patients carrying at least one S3P allele had significantly higher anti-CCP Ab titers, with patients homozygous for HLA-DRB1 *04:05 having the highest levels. A similar relationship was not found with HLA-DRB1 *01:01 despite its strong effect on monocyte counts.
conclusionsThis is the first study to demonstrate a significant association between SE alleles and peripheral blood monocyte counts in RA. The results obtained suggest that specific SE alleles, particularly S3P alleles, contribute to the early pathogenesis of RA by enhancing monocyte-driven immune activation and anti-CCP Ab production.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.